| Literature DB >> 36059291 |
Rajeshwar Yadav1, Swati Pathak1, Satisha Hegde2.
Abstract
Purpose Atherosclerosis is a generalized disorder and can begin to develop in the abdominal aorta by the second decade of life. The nature of these lesions in coronaries and aorta is atheromatous and less sclerotic when compared to peripheral arteries. A broad spectrum of presentations and different types of lesions demand a personalized approach for the best outcome. This study is a case series analysis of major vascular revascularization. We aim to study various revascularization surgeries and underline the wide range of vascular lesions to which it is applied. Methods This is a study based on accrual patient records of all major vascular revascularization surgical/interventional procedures conducted at a tertiary care center for one year. Results A total of 110 patients were operated on for vascular diseases. Among these, 86 (78.81%) were men, and 24 (21.81%) were women. The femoropopliteal segment (n=47) was most commonly involved, followed by the common carotid artery (n=20). Atherosclerosis was the main cause of vascular occlusion (81.8%), followed by aneurysm of the aorta (14.5%) and coarctation of the aorta (2.7%). Smoking (62.2%) accounted to be the leading risk factor, followed by hypertension, diabetes, and hyperlipidemia. The majority of patients had a good outcome (92.7%). Minor complications (7.3%) include seroma formation and wound infection, which were managed conservatively. The repair was performed by autologous vein graft in 30% of patients and by synthetic polytetrafluoroethylene (PTFE) graft in 70% of patients. Carotid artery stenting was the most common endovascular procedure performed (n=5). Femoropopliteal bypass grafting was the most common procedure, followed by carotid endarterectomy (n=20) and aortofemoral bypass (n=14). Conclusion The application of novel techniques such as cavo-atrial shunt in Budd-Chiari syndrome calls attention to the broadened scope of vascular surgery, and the modification of the conventional method of the carotid endarterectomy underscores the evolution of vascular revascularization. Our study thus highlighted that a wide spectrum of vascular lesions ranging from carotid artery stenosis to extensive below-knee disease, either atherosclerotic or aneurysmal, can be successfully treated with surgical revascularization techniques.Entities:
Keywords: aorta; aortofemoral bypass; aortoiliac; carotid endarterectomy; cavo-atrial shunt; peripheral arterial disease (pad); pta; revascularization
Year: 2022 PMID: 36059291 PMCID: PMC9433795 DOI: 10.7759/cureus.27595
Source DB: PubMed Journal: Cureus ISSN: 2168-8184
Surgical revascularization procedures
| Surgical procedures/disease | Number of patients | Outcome |
| Ascending to descending aorta bypass graft under CPB in complete interruption of arch distal to the left subclavian artery | 3 | Excellent |
| Inter-positional synthetic graft in infrarenal aortic aneurysm not involving common iliac vessels | 6 | Excellent |
| Aortobifemoral grafting in infrarenal aortic aneurysm extending up to bilateral common iliac vessels | 8 | Excellent |
| Extraperitoneal thoracobifemoral bypass grafting | 5 | Good outcome (n=4), seroma formation (n=1 ) managed conservatively |
| Carotid endarterectomy | 20 | Excellent |
| Cavo-atrial shunt for Budd-Chiari syndrome | 1 | Excellent |
| Right subclavian to brachial bypass in huge subclavian artery aneurysm | 1 | Wound infection managed conservatively |
| Left subclavian to right axillary bypass | 3 | Excellent |
| Axillo-radial bypass | 3 | Good outcome (n=2), wound infection (n=1) managed conservatively |
| Femoro-femoral crossover bypass | 10 | Excellent (n=8), seroma formation (n=2) managed conservatively |
| Common femoral to distal femoral bypass | 12 | Excellent (n=11), seroma formation (n=1) managed conservatively |
| Femoropopliteal bypass | 15 | Excellent |
| Femorotibial bypass | 10 | Excellent (n=9), seroma formation (n=1) managed conservatively |
| Axillo-bifemoral (extra-anatomical ) bypass | 2 | Excellent |
Percutaneous endovascular procedures
| Percutaneous interventions/disease | Number of patients | Outcome |
| Stenting for occlusion of the suprarenal aorta | 2 | Excellent |
| Stenting for abdominal infrarenal aortic aneurysm | 1 | Conversion to surgical bypass grafting |
| Unilateral renal artery stenting | 1 | Excellent |
| Subclavian artery stenting | 2 | Excellent |
| Carotid artery stenting | 5 | Excellent |
Lesions and procedures performed
| Disease | Total patients | Surgical revascularization | Percutaneous interventions |
| Carotid artery stenotic/near-total occlusive lesions | 25 | 20 | 5 |
| Coarctation of the aorta | 3 | 3 | 0 |
| Aortic aneurysm/atheroslerotic lesion not involving common iliac vessels | 7 | 6 | 1 (converted to inter-positional bypass graft) |
| Abdominal aortic aneurysm/atheroslerotic lesion involving common iliac vessels | 7 | 7 | 0 |
| Subclavian artery aneurysm/atheroslerotic lesion | 6 | 4 | 2 |
| Axillary artery stenotic/occlusive lesion | 1 | 1 | 0 |
| Brachial artery aneurysm atheroslerotic lesion | 2 | 2 | 0 |
| Suprarenal aorta block | 3 | 1 | 2 |
| Unilateral renal artery stenosis | 1 | 0 | 1 |
| Femoral artery stenosis/occlusive/aneurysm | 22 | 22 | 0 |
| Below-knee bypass | 25 | 25 | 0 |
| Extra-anatomical bypass for thoracic aorta stenotic/occlusive lesions | 7 | 7 | 0 |
| Cavo-atrial shunt for Budd-Chiari syndrome | 1 | 1 | 0 |
| Total | 110 | 99 | 11 |
Figure 1Cavo-atrial shunt for Budd-Chiari syndrome using an 18-mm polytetrafluoroethylene tubular graft
Figure 2Carotid endarterectomy (preoperative angiography image (left) and intraoperative image (right))
Assessment of outcomes
ABI and claudication pain were monitored in occlusive/aneurysmal lesions of peripheral vessels.
Cardiac/cerebral events were monitored in occlusive/aneurysmal lesions of proximal vessels (carotid and ascending/descending aorta).
ABI: ankle-brachial index; %: percentage of patients
| Assessment of outcomes | One month | Three months | Six months |
| Improvement in ABI | 91.9% | 96.7% | 98.3% |
| Abrogation of claudication pain | 92.3% | 95.3% | 96.9% |
| Cardiac/cerebral vascular events | 0 | 0 | 15% |
| Redo intervention | 0 | 0 | 0 |